$2.76
-0.14 (-4.83%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+660.9% upside
Low Target
$13.91
Average Target
$21.00
High Target
$28.26
Current Price
$2.76
Current
$2.76
$2.76
Target
$21.00
$21.00
$13.91
$21.00 avg
$28.26
Scenario Analysis
Bear Case
$13.91
404.0%
Low target
Base Case
$21.00
+660.9%
Avg target
Bull Case
$28.26
+923.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.38
-48.7% from high
52-Week Low
$2.23
+23.8% from low
Target vs 52W High
$21.00
+290.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |